切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2019, Vol. 08 ›› Issue (05) : 201 -207. doi: 10.3877/cma.j.issn.2095-3216.2019.05.003

所属专题: 文献

论著

基于"中医传承辅助平台"分析探讨陈以平教授治疗IgA肾病用药规律的研究
朱逸云1, 王琳1,(), 陈以平1   
  1. 1. 200032 上海中医药大学附属龙华医院肾病科
  • 收稿日期:2018-10-31 出版日期:2019-10-28
  • 通信作者: 王琳
  • 基金资助:
    上海市进一步加快中医药事业发展三年行动计划(ZY(2018-2010)-FWTX-6025)

Analysis and discussion of the rules of treatment of IgAN by Professor Chen Yiping by means of the "Traditional Chinese Medicine Inheritance Support System"

Yiyun Zhu1, Lin Wang1,(), Yiping Chen1   

  1. 1. Department of Nephrology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China
  • Received:2018-10-31 Published:2019-10-28
  • Corresponding author: Lin Wang
  • About author:
    Corresponding author: Wang Lin, Email:
引用本文:

朱逸云, 王琳, 陈以平. 基于"中医传承辅助平台"分析探讨陈以平教授治疗IgA肾病用药规律的研究[J]. 中华肾病研究电子杂志, 2019, 08(05): 201-207.

Yiyun Zhu, Lin Wang, Yiping Chen. Analysis and discussion of the rules of treatment of IgAN by Professor Chen Yiping by means of the "Traditional Chinese Medicine Inheritance Support System"[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2019, 08(05): 201-207.

目的

探讨和总结我国中西医结合肾病学科奠基人之一、上海市名中医陈以平教授治疗IgA肾病的临床经验和用药规律。

方法

收集陈教授治疗IgA肾病典型医案500份,通过"中医传承辅助平台"软件,对用药特点、配伍规律、随证加减、治则治法等进行数据挖掘及聚类分析。总结陈以平教授对于IgA肾病不同临床表现的常用治法及方药。通过熵聚类研究分析常见症状的常用药味组合。

结果

共500份病例纳入研究,共计1 499条医案;共得251味药物,常用中药出现频次从高到低分别为白术、苍术、生黄芪、薏苡仁、黄精等20味。以血尿为主,治以滋阴清热、健脾化湿法。以蛋白尿为主,治以疏利少阳、健脾益肾法。以慢性肾功能不全为主,治以斡旋三焦、活血泄浊法。以肾功能不全伴高尿酸血症为主,治以益肾泄浊、活血通络法。

结论

通过数据挖掘技术以方测证,佐证了陈老治疗IgA肾病寒温并用、苦辛并进、攻补兼施,疏利三焦的学术思想。

Objective

To explore and summarize the clinical experience and medication rules in IgA nephropathy by the famous Chinese doctor Chen Yiping, one of the founders of the nephrology of integrated traditional Chinese and western medicine in China.

Methods

Data of 500 typical cases of IgA nephropathy treated by Professor Chen Yiping were collected. The "TCM Inheritance Support System" (V2.5) was used for data mining and cluster analysis in terms of drug characteristics, compatibility rules, addition and subtraction with the syndrome, and treatment principles and methods. The common methods and prescriptions of Professor Chen Yiping for different clinical manifestations of IgA nephropathy were summarized. Entropy clustering was used to analyze the common medicine pairs for common symptoms.

Results

500 cases were included in the study, with a total of 1, 499 medical records. Totally, 251 kinds of drugs were used. The frequencies of 20 common traditional Chinese medicines used from high to low were Atractylodes rhizome, raw Astragalus, Coix seed, and Polygonati rhizome, etc. For IgA nephropathy characterized by hematuria, the method of nourishing Yin and clearing heat as well as invigorating the spleen and eliminating dampness was used. For IgA nephropathy characterized by proteinuria, the method of smoothing Shaoyang as well as nourishing the spleen and kidneys was used. For IgA nephropathy characterized by chronic renal insufficiency, the method of mediating Sanjiao as well as activating the blood circulation and draining the turbidity was used. For IgA nephropathy characterized by renal insufficiency complicated with hyperuricemia, the method of tonifying the kidneys as well as activating the blood circulation and draining the turbidity was used.

Conclusion

By means of the data mining techniques, the results supports the academic ideas of Professor Chen Yiping in the treatment of IgA nephropathy through combination of both cold and warm medicines, both bitter and hot medicines, both tonification and purgation medicines, and the method of clearing the Sanjiao.

表1 纳入分析处方用药频次及类别功效统计
图1 使用中药在四气五味中所占比重
图2 使用中药归经分布
表2 血尿三药关联规则分析结果(选取前20位)
图3 血尿药物关联规则网络展示图
表3 蛋白尿三药关联规则分析结果(选取前20位)
图4 蛋白尿药物关联规则网络展示图
表4 慢性肾功能不全三药关联规则分析结果(选取前20位)
图5 慢性肾功能不全药物关联规则网络展示图
表5 慢性肾功能不全伴高尿酸血症三药关联规则分析结果(选取前20位)
图6 慢性肾功能不全伴高尿酸血症药物关联规则网络展示图
表6 熵聚类用药核心组结果
图7 熵聚类用药核心组合网络图
[1]
叶任高.内科学[M].5版.北京:人民卫生出版社,2001:542-544.
[2]
Le W, Liang S, Hu Y, et al. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population [J]. Nephrol Dial Transplant, 2012, 27(4): 1479-1485.
[3]
邓跃毅,陈万佳.IgAN中医中药治疗[J].内科理论与实践,2016,11(3):161-164.
[4]
王海燕.肾脏病学[M].3版.北京:人民卫生出版社,2008:536-537.
[5]
唐仕欢,陈建新,卢朋,等. 中医传承辅助平台的开发与应用[M].福州:福建科学技术出版社,2013:22-52.
[6]
陈香美,谢院生.重视延缓IgAN进展的基础和临床研究[J].中华肾脏病杂志,2004,20(4):235-237.
[7]
福州市人民医院,校释.脉经校释[M].北京:人民卫生出版社,1984:82.
[8]
刘玉宁,邓跃毅,王立红.陈以平教授治疗IgAN的临证经验[J].中国中西医结合肾病杂志,2003,4(6):314-315.
[9]
陈香美,陈以平,谌贻璞,等.286例IgAN中医辨证与肾脏病理关系的多中心前瞻性研究[J].中国中西医结合杂志,2004,24(2):101-105.
[10]
Itoh A, Iwase H, Takatani T, et al. Tonsillar IgA1 as a possible source of hypoglycosylated IgA1 in the serum of IgA nephropathy patients [J]. Nephrol Dial Transplant, 2003, 18(6): 1108-1114.
[11]
王琳.陈以平教授诊治中重症IgAN学术思想研究[J].中国中西医结合肾病杂志,2010,11(12):1043-1045.
[12]
陈慧勇,藏秀娟,马莉莉,等.上海市松江区成人血尿酸水平与肾脏损害的关系[J].复旦学报,2013,40(5):562-567.
[13]
邢儒伶,陈以平,金佳鹤.益肾泄浊方治疗痛风性肾病并慢性肾衰竭48例临床研究[J].中国中西医结合肾病杂志,2008,9(6):529-531.
[14]
马志芳,陈以平,郭华伟.陈以平治疗痛风性肾病的经验运用-附35例临床报告[J].世界中医药,2012,7(6):515-516.
[15]
Coe FL. Uric acid and calcium oxalate nephrolithiasis [J]. Kidney Int, 1983, 24(3): 392-403.
[16]
Koka RM, Huang E, Lieske JC. Adhesion of uric acid crystals to the surface of renal epithelial cells [J].Am J Physiol Renal Physiol, 2000, 278(6): F989-F998.
[17]
Umekawa T, Chegini N, Khan SR.Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals [J]. Nephrol Dial Transplant, 2003, 18(4): 664-669.
[18]
Gibson T, Highton J, Potter C, et al. Renal impairment and gout [J]. Ann Rheum Dis, 1980, 39(5): 417-423.
[19]
刘志红,胡伟新,黎磊石,等.大黄素对肾脏系膜细胞增殖细胞核抗原表达的影响[J].肾脏病与透析肾移植杂志,1994,2(5):45.
[20]
吴连英.中药大黄炮制研究Ⅱ.炮制对大黄泻浊作用泻下成分的影响[J].中药通报,1983,8(2):20.
[1] 董才韬, 周大为, 梁峻滔, 叶啟发. 免疫抑制剂治疗肾移植术后复发性IgA肾病研究进展[J]. 中华移植杂志(电子版), 2021, 15(06): 365-369.
[2] 邓荣珍, 罗宇珍, 赵若蓓, 邓杨, 廖蕴华, 潘玲. 血脂与IgA肾病患者肾脏预后的相关性研究[J]. 中华肾病研究电子杂志, 2023, 12(01): 13-19.
[3] 谭惠丰, 曹沛莲, 张慧, 强胜. Notch信号通路对IgA肾病大鼠外周血Th17细胞数量及功能的影响[J]. 中华肾病研究电子杂志, 2021, 10(05): 259-264.
[4] 金美玲, 李艳春, 王佳, 张敏, 李新, 赵素梅, 徐晨. 基于生物信息学的IgA肾病基因富集及免疫细胞浸润分析[J]. 中华肾病研究电子杂志, 2021, 10(04): 205-213.
[5] 董玉, 尚顺来, 李清刚, 陈香美. 来氟米特联合甲泼尼龙治疗IgA肾病的疗效观察[J]. 中华肾病研究电子杂志, 2020, 09(03): 102-106.
[6] 谢院生. 对IgA肾病治疗的新认识[J]. 中华肾病研究电子杂志, 2020, 09(03): 144-144.
[7] 张岩, 段姝伟, 蔡广研, 陈香美. 补体在IgA肾病发生发展中的作用[J]. 中华肾病研究电子杂志, 2019, 08(06): 269-272.
[8] 陈玉贞, 徐家云. 来氟米特联合中小剂量糖皮质激素治疗慢性进展性IgA肾病的疗效及安全性分析[J]. 中华肾病研究电子杂志, 2019, 08(05): 208-212.
[9] 谢院生, 陈香美. IgA肾病的诊治研究进展[J]. 中华肾病研究电子杂志, 2019, 08(01): 1-5.
[10] 袁川, 列才华. IgA肾病IgA1糖基化异常及相关中医药干预进展[J]. 中华肾病研究电子杂志, 2018, 07(03): 139-142.
[11] 段姝伟, 张岩, 吴杰, 孟金铃, 刘述文, 谢院生, 蔡广研. 少量蛋白尿IgA肾病患者镜下血尿与病理指标的相关性分析[J]. 中华肾病研究电子杂志, 2018, 07(03): 102-106.
[12] 郑维, 吕杨, 耿晓东, 洪权, 吴镝. IgA肾病患者肾脏组织中差异细胞因子的探索研究[J]. 中华肾病研究电子杂志, 2018, 07(03): 97-101.
[13] 刘键, 段姝伟, 陈香美. IgA肾病预后评估方法研究进展[J]. 中华肾病研究电子杂志, 2017, 06(05): 233-238.
[14] 朱合, 徐道亮, 刘昌华, 伍刚, 高波, 毕光宇. IgA肾病发病机制-IgA1异常糖基化与免疫异常[J]. 中华肾病研究电子杂志, 2017, 06(04): 182-185.
[15] 吴萌, 吴国仲, 王贵红, 端靓靓, 施杰, 王旭, 余婷, 刘伟. IgA肾病患者中性粒细胞-淋巴细胞比值与肾小管萎缩/间质纤维化相关性分析[J]. 中华临床医师杂志(电子版), 2023, 17(9): 972-979.
阅读次数
全文


摘要